as on November 7, 2025 at 2:29 am IST
Day's Low
Day's High
3.57%
Downside
0.64%
Upside
52 Week's Low
52 Week's High
45.77%
Downside
1.70%
Upside
Check Madrigal Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.8B
EPS (TTM)
-12.605
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-306.0M
Revenue (TTM)
740.6M
Profit Margin
-39.04%
Return On Equity TTM
-41.22%
Compare market cap, revenue, PE, and other key metrics of Madrigal Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $10.8B | 294.37% | NA | -39.04% | |
| BUY | $39.6B | 470.1% | -16.34 | -264.83% | |
| BUY | $57.4B | 236.95% | 1448.53 | 1.36% | |
| BUY | $105.8B | 88.96% | 29.32 | 31.35% | |
| BUY | $67.7B | 11.91% | 15.43 | 32.13% |
The Madrigal Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Madrigal Pharmaceuticals, Inc. investment value today
Current value as on today
₹1,42,742
Returns
₹42,742
(+42.74%)
Returns from Madrigal Pharmaceuticals, Inc. Stock
₹37,706 (+37.71%)
Dollar Returns*
₹5,036 (+5.04%)
Based on 21 analysts
80.95%
Buy
14.29%
Hold
4.76%
Sell
Based on 21 analysts, 80.95% of analysts recommend a 'BUY' rating for Madrigal Pharmaceuticals, Inc.. Average target price of $535.71
Get share price movements and forecasts by analysts on Madrigal Pharmaceuticals, Inc..
What analysts predicted
8.78%UPSIDE
Target Price
$535.71
Current Price
$488.65
Analyzed by
21 Analysts
Target
$535.71
Madrigal Pharmaceuticals, Inc. target price $535.71, a slight upside of 8.78% compared to current price of $488.65. According to 21 analysts rating.
Search interest for Madrigal Pharmaceuticals, Inc. Stock has increased by 63% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:63% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, MDGL stock has moved up by 13.6%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 928.5% return, outperforming this stock by 292.5%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 160.7% return, outperforming this stock by 126.6%
| Organisation | Madrigal Pharmaceuticals, Inc. |
| Headquarters | Four Tower Bridge, West Conshohocken, PA, United States, 19428 |
| Industry | Health Technology |
| CEO | Mr. William J. Sibold |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. William J. Sibold | CEO, President & Director |
Ms. Mardi C. Dier | Executive VP & CFO |
Ms. Shannon Kelley | Executive VP, Chief Legal Officer & Corporate Secretary |
Mr. Mark Underwood | Executive Vice President of Business Planning & Operations |
Mr. Ronald Filippo | Executive VP & Chief Information Officer |
Ms. Tina E. Ventura | Chief Investor Relations Officer |
Mr. Edward Chiang | Senior Vice President of Clinical & Technical Operations |
Dr. Rebecca A. Taub M.D. | Founder, Senior Scientific & Medical Advisor and Director |
Ms. Carole Huntsman | Executive VP & Chief Commercial Officer |
Mr. Clint Wallace | Executive VP & Chief Human Resources Officer |
Madrigal Pharmaceuticals, Inc. share price today is $488.65 as on at the close of the market. Madrigal Pharmaceuticals, Inc. share today touched a day high of $491.78 and a low of $471.22.
Madrigal Pharmaceuticals, Inc. share touched a 52 week high of $496.98 on and a 52 week low of $265 on . Madrigal Pharmaceuticals, Inc. stock price today i.e. is closed at $488.65,which is 1.68% down from its 52 week high and 84.40% up from its 52 week low.
Madrigal Pharmaceuticals, Inc. market capitalisation is $0.01T as on .
Indian investors can start investing in Madrigal Pharmaceuticals, Inc. (MDGL) shares with as little as ₹88.566 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Madrigal Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Madrigal Pharmaceuticals, Inc. share’s latest price of $488.65 as on November 7, 2025 at 2:29 am IST, you will get 0.0205 shares of Madrigal Pharmaceuticals, Inc.. Learn more about
fractional shares .
Madrigal Pharmaceuticals, Inc. stock has given 294.37% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?